Claude D. Vaislic, MDExpert Witness for the French Supreme Court
French National Academy of Surgery
Consultant Cardiac Surgeon
CHP Parly 2
Le Chesnay, France
Domenico Valenti, DMChir, PhD, FRCS, FRCS(Ed), FEBVSProfessor of Vascular Surgery
King's College Hospital
Consultant Vascular Surgeon
King's College Hospital
London, United Kingdom
DOMENICO VALENTI, DMCHIR, PHD, FRCS, FRCS(ED), FEBVS - SCHEDULE FOR VEITHsymposium™
Friday, November 22, 2024
PresenterSESSION 82: MORE CAROTID RELATED NEW DEVELOPMENT TOPICS RELATED TO TCAR, CAS AND CEA, NEW DEVICES, MESH COVERED STENTS, MINI-INCISION CEA, SIGNIFICANCE OF DW MRI DEFECTS, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONSWith Crescendo TIAs And Thrombus Overlying A Plaque What Is The Best Invasive Treatment And When Should It Be Performed
11:48 AM - 11:53 AM
Jos C. van den Berg, MD, PhDAssociate Professor of Radiology
University of Bern, Switzerland
Interventional Radiologist
Clinica Luganese Moncucco
Lugano, Switzerland
JOS C. VAN DEN BERG, MD, PHD - SCHEDULE FOR VEITHsymposium™
Tuesday, November 19, 2024
PresenterSESSION 20: MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT – EVALUATING ARTERIAL ANATOMY AND TREATMENT OUTCOMES WITH CLTI The Value Of Distal Angiography, Selective And Subselective, In The Treatment Of Lesions Causing CLTI
2:16 PM - 2:21 PM
PresenterSESSION 22: MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE, CLTI AND ITS TREATMENTSHow To Size Lower Extremity Target Arteries For Endo Treatments Accurately Using Intravascular Ultrasound (IVUS): How Does It Help
4:48 PM - 4:53 PM
Wednesday, November 20, 2024
PresenterSESSION 30: NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI) Characteristics Of All The Commercial Systems For Mechanically Removing Clot To Treat ALI: What Are The Advantages And Disadvantages Of Each
5:28 PM - 5:33 PM
PresenterSESSION 45: MORE HOT AORTIC TOPICSCoil Embolization To Treat Aortic ‘Blebs’, Entry-Tears And Pseudoaneurysms: How Does It Work, When Is It Indicated, And Results
4:00 PM - 4:05 PM
Thursday, November 21, 2024
PresenterSESSION 61: NEW OR IMPROVED ENDOVASCULAR DEVICE COMBINATIONS FOR LOWER EXTREMITY TREATMENTS: ANGIOPLASTY BALLOON IMPROVEMENTS Unfavorable Balloon (Candy) Wrap Can Cause Dissections With Angioplasty: What Is The Mechanism: How Can It Be Recognized And Dissection Avoided: When Does Dissection Have To Be Treated And When Not
4:00 PM - 4:05 PM
Joost van Herwaarden, MD, PhDProfessor of Vascular Surgery
University Medical Center Utrecht
University Medical Center Utrecht
Utrecht, The Netherlands
Isabelle Van Herzeele, MD, PhDUniversity Hospital Ghent
Consultant Vascular Surgery
Ghent University Hospital, Belgium
Ghent, Belgium
ISABELLE VAN HERZEELE, MD, PHD - SCHEDULE FOR VEITHsymposium™
Thursday, November 21, 2024
PresenterSESSION 51: PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAS, COMPLEX AAAS, TAAAS AND RELATED TOPICS Selection Of Patients With Ruptured AAAs For Noninvasive (Comfort) Care Based On Scoring System Or Advanced Age Is Inappropriate And Unfair To Some Patients
1:06 PM - 1:11 PM
Power Point Presentation with Synched Audio
MISCELLANEOUS ASSIGNMENTS AT VEITHsymposium
THE SVS/ESVS/NICE/ACC/AHA DEBATES ON GUIDELINES FOR THE MANAGEMENT OF ABDOMINAL AORTIC ANEURYSMS
FRIDAY, NOVEMBER 22, 2024
PRESENTER
11:10 AM - 11:15 AM
Debate: ESVS: Selection Of Patients With A Ruptured Abdominal Aortic Aneurysm For Palliation Based Entirely On Scoring Systems Or Solely On Advanced Age Is Not Recommended
Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi)Professor of Vascular Surgery
The University Of New South Wales
Vascular Surgeon
Prince of Wales Hospital
Sydney, Australia
RAMON L. VARCOE, MBBS, MS, FRACS, PHD, MMED (CLINEPI) - SCHEDULE FOR VEITHsymposium™
Wednesday, November 20, 2024
Session ModeratorSESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE) PresenterSESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE) An Update Of The 2-Year Results And Economic Cost Effectiveness Analysis Of The LIFE-BTK Randomized Controlled Comparison Of Abbott’s Esprit Drug-Eluting Resorbable Scaffold (DRS) With Plain Old Balloon Angioplasty (POBA): When Will DRSs Make A Difference
8:29 AM - 8:34 AM
PresenterSESSION 43: MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAS ARE NOT TIME BOMBS WAITING TO EXPLODE A Direct Comparison Of Major Contemporary EVAR Devices – Looking At Long-Term Efficacy And Patient Survival Using Big Data And Linkage Techniques
1:12 PM - 1:17 PM
Thursday, November 21, 2024
PresenterSESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27) 5-Year Results With The VBX Covered Stent For Aortoiliac Disease: Patency Rates, Advantages And Cost Effectiveness
2:42 PM - 2:47 PM
Power Point Presentation with Synched Audio
Ravi K. Veeraswamy, MDProfessor of Vascular Surgery
The Medical University of South Carolina
Chief, Division of Vascular Surgery
The Medical University of South Carolina
Charleston, South Carolina
Frank J. Veith, MDProfessor of Surgery
The Cleveland Clinic Lerner College of Medicine and New York University
The William J. von Liebig Chair in Vascular Surgery
New York University Medical Center
Cleveland, Ohio and New York, New York
FRANK J. VEITH, MD - SCHEDULE FOR VEITHsymposium™
Tuesday, November 19, 2024
PresenterSESSION 1: PROGRESS IN CORONARY ARTERY STENTING, TRANSCATHETER VALVE REPLACEMENT, AND TREATMENT OF ASCENDING AORTIC DISEASEOpening Remarks
6:50 AM - 6:55 AM
PresenterSESSION 17: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH - PART 1Introduction To The Symposium
7:00 AM - 7:05 AM
Wednesday, November 20, 2024
Session ModeratorSESSION 29: LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES Thursday, November 21, 2024
Session ModeratorSESSION 47: EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES, CONCEPTS Session ModeratorSESSION 51: PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAS, COMPLEX AAAS, TAAAS AND RELATED TOPICS Friday, November 22, 2024
Session ModeratorSESSION 82: MORE CAROTID RELATED NEW DEVELOPMENT TOPICS RELATED TO TCAR, CAS AND CEA, NEW DEVICES, MESH COVERED STENTS, MINI-INCISION CEA, SIGNIFICANCE OF DW MRI DEFECTS, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONSSaturday, November 23, 2024
Session ModeratorSESSION 109: AORTIC AND CAROTID TOPICS TOO IMPORTANT TO MISS MISCELLANEOUS ASSIGNMENTS AT VEITHsymposium
THE SVS/ESVS/NICE/ACC/AHA DEBATES ON GUIDELINES FOR THE MANAGEMENT OF ABDOMINAL AORTIC ANEURYSMS
FRIDAY, NOVEMBER 22, 2024
CO-PRESENTER
10:30 AM - 10:35 AM
Introduction
OPEN VASCULAR TECHNIQUES
FRIDAY, NOVEMBER 22, 2024
MODERATOR
3:00 PM - 4:02 PM
Maarit Venermo, MD, PhDProfessor of Vascular Surgery
Helsinki University
Head of the Department
Helsinki University Hospital
Helsinki, Finland
Hence J.M. Verhagen, MD, PhDProfessor and Chief of Vascular Surgery
University Medical Center Rotterdam
Professor
Erasmus University Medical Center Rotterdam
Rotterdam, The Netherlands
Eric L.G. Verhoeven, MD, PhDProfessor of Vascular Surgery
Paracelsus Medical University Nuremberg
Chief, Department of Vascular and Endovascular Surgery
General Hospital Nuremberg
Nuremberg, Germany
ERIC L.G. VERHOEVEN, MD, PHD - SCHEDULE FOR VEITHsymposium™
Tuesday, November 19, 2024
Session ModeratorSESSION 4: MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADS, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAS) PresenterSESSION 4: MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADS, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAS) Update On F/B/EVAR For Degenerative And Post TBAD TAAAs: The Value Of Inner Branched Devices: Value Of The BeBack Catheter (Bentley) To Cross The Dissection Flap And For Other Purposes
10:54 AM - 10:59 AM
Thursday, November 21, 2024
Session ModeratorSESSION 55: NEW OR IMPROVED DEVICES FOR INFRARENAL AAA REPAIR WITH STANDARD EVAR PresenterSESSION 49: MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAS AND TAAAS; AND RELATED TOPICS Update On Optimal Bridging Stent-Grafts For F/B/EVAR: Advantages And Disadvantages Of The BeGraft, BeGraft Plus (Bentley) And Advanta (iCast – Getinge): Experience With >2,000 Target Vessels
9:50 AM - 9:55 AM
PresenterSESSION 54: PROGRESS IN RADIATION SAFETY AND MORE NEW CONCEPTS, DEVICES AND TECHNIQUES Intravascular Lithotripsy (From Shockwave): A New Valuable Tool To Facilitate Access For Large Sheaths In F/BEVAR
4:38 PM - 4:43 PM
PresenterSESSION 55: NEW OR IMPROVED DEVICES FOR INFRARENAL AAA REPAIR WITH STANDARD EVAR 10-Year Results With The Gore Excluder Endograft For EVAR Show Its Durability: From The GREAT Registry
7:54 AM - 7:59 AM
Fabio Verzini, MD, PhD, FEBVSFull Professor of Vascular Surgery
University of TURIN
Director, Vascular Surgery
AOU Città della Salute e della Scienza di Torino
Turin, Italy
Todd R. Vogel, MD, MPHProfessor of Surgery, Vice-Chair of Health Services Research
University of Missouri-Columbia
Chief of Vascular Surgery
University of Missouri Health - Heart & Vascular Center
Columbia, Missouri
TODD R. VOGEL, MD, MPH - SCHEDULE FOR VEITHsymposium™
Wednesday, November 20, 2024
PresenterSESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE) Update On Atherectomy Devices: Do They Still Have A Role In 2024: Which One Or Ones Are Best: Has Their Benefit Been Proven
7:59 AM - 8:04 AM
Thursday, November 21, 2024
PresenterSESSION 47: EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES, CONCEPTS A Patient-Centric Smartphone App For Monitoring Vascular And Endovascular Procedures: What Does It Measure And How Is It Helpful
6:56 AM - 7:01 AM
